---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-025921"
form_type: "8-K"
ticker: "PEPG"
cik: "0001835597"
company_name: "PepGen Inc."
filed_at: "2024-02-07T23:59:59+00:00"
generated_at: "2026-06-06T07:18:03.777825+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PepGen prices $80.1M common stock offering of 7.53M shares at $10.635 per share

## Summary
- Gross proceeds ~$80.1M; net proceeds ~$76.4M after underwriting discounts and expenses.
- Offering led by RA Capital Management; 11 institutional investors including Adage, Frazier, Janus.
- Net proceeds to fund R&D and clinical development of oligonucleotide therapies; cash runway into 2026.
- Offering expected to close February 9, 2024; Leerink Partners sole bookrunner.

## SEC filing metadata
- accession: 0001193125-24-025921
- form_type: 8-K
- ticker: PEPG
- cik: 0001835597
- company_name: PepGen Inc.
- filed_at: 2024-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/0001193125-24-025921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/d695469d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-025921
- JSON: https://secwatch.observer/filing/0001193125-24-025921.json
- Plain text: https://secwatch.observer/filing/0001193125-24-025921.txt

## Key facts
- Material Agreements
  PepGen Inc. entered into Underwriting Agreement with Leerink Partners LLC valued at Underwriting Agreement for 7,530,000 shares of common stock at $10.635 per share, net proceeds appro (effective 2024-02-06).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Leerink Partners LLC
  - Value: Underwriting Agreement for 7,530,000 shares of common stock at $10.635 per share, net proceeds appro
  - Effective: 2024-02-06
  source text: On February 6, 2024, PepGen Inc. (the " Company ") entered into an underwriting agreement (the " Underwriting Agreement ") with Leerink Partners LLC, as underwriter, pursuant to which the Company agreed to issue and sell an aggregate of 7,530,000 shares (the " Shares ") of its common stock, par value $0.0001 per share (the " Common Stock "), at a price to the public of $10.635 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/0001193125-24-025921-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.